Rimegepant for migraine prevention in clinical practice: A multicenter study including patients with prior anti-CGRP monoclonal antibody failure (GEMA project)
Ana Beatriz Gago‐Veiga, Ana Belén López-Rodríguez, Marina Sanchez Jimenez, Alvaro Iglesias Rubio et autres